Calumet, Inc. Receives Consensus 'Hold' Rating from Brokerages
Apr 5, 2026
Eight brokerages assigned a 'Hold' consensus to Calumet Inc. with a $30.17 price target, following Q4 results showing EPS beats and 9.4% revenue growth despite losses.
Show all 57 updates